The emerging role of asymmetric dimethylarginine as a novel cardiovascular risk factor.
about
Effect of diet and omega-3 fatty acid intervention on asymmetric dimethylarginine.Gaseous mediators nitric oxide and hydrogen sulfide in the mechanism of gastrointestinal integrity, protection and ulcer healingAsymmetric dimethylarginine and cardiovascular risk: systematic review and meta-analysis of 22 prospective studiesTranssulfuration pathway thiols and methylated arginines: the Hunter Community StudyFarnesoid X receptor agonist reduces serum asymmetric dimethylarginine levels through hepatic dimethylarginine dimethylaminohydrolase-1 gene regulationPostprandial Metabolism of Macronutrients and Cardiometabolic Risk: Recent Developments, Emerging Concepts, and Future Directions.Dimethylarginine dimethylaminohydrolase II overexpression attenuates LPS-mediated lung leak in acute lung injury.Therapeutic strategies for targeting excessive central sympathetic activation in human hypertensionMechanisms of nitric oxide synthase uncoupling in endotoxin-induced acute lung injury: role of asymmetric dimethylarginine.Endothelial dysfunction in diabetes mellitus: molecular mechanisms and clinical implications.Rho/ROCK signal cascade mediates asymmetric dimethylarginine-induced vascular smooth muscle cells migration and phenotype change.Helicobacter pylori eradication lowers serum asymmetric dimethylarginine levels.Protein arginine methylation is more prone to inhibition by S-adenosylhomocysteine than DNA methylation in vascular endothelial cells.Dimethylarginine dimethylaminohydrolase 1 modulates endothelial cell growth through nitric oxide and AktThe Role of Obesity in Preeclampsia.Plasma asymmetric dimethylarginine and adverse events in patients with atrial fibrillation referred for coronary angiogram.Vascular Nitric Oxide: Formation and Function.DDAH1 deficiency attenuates endothelial cell cycle progression and angiogenesis.Testosterone and phosphodiesterase type-5 inhibitors: new strategy for preventing endothelial damage in internal and sexual medicine?Plasma asymmetric dimethylarginine and L-arginine levels in Chinese patients with essential hypertension without coronary artery disease.Reference intervals for plasma L-arginine and the L-arginine:asymmetric dimethylarginine ratio in the Framingham Offspring CohortEffects of vitamin C on intracoronary L-arginine dependent coronary vasodilatation in patients with stable angina.Pathogenesis of aortic stenosis: not just a matter of wear and tearPathogenesis of aortic sclerosis: association with low BMI, tissue nitric oxide resistance, but not systemic inflammatory activation.Evaluation of ADMA-DDAH-NOS axis in specific brain areas following nitroglycerin administration: study in an animal model of migraine.Plasma proteome and metabolome characterization of an experimental human thyrotoxicosis modelInvolvement of DDAH/ADMA/NOS/cGMP and COX-2/PTGIS/cAMP Pathways in Human Tissue Kallikrein 1 Protecting Erectile Function in Aged RatsElevated levels of asymmetric dimethylarginine (ADMA) as a marker of cardiovascular disease and mortality.Measurement of asymmetric dimethylarginine in plasma: methodological considerations and clinical relevance.Asymmetric dimethylarginine (ADMA) and cardiovascular disease: insights from prospective clinical trials.Biomarkers and mechanisms of drug-induced vascular injury in non-rodents.Asymmetric dimethylarginine (ADMA): a novel risk marker in cardiovascular medicine and beyond.High levels of asymmetric dimethylarginine are strongly associated with low HDL in patients with acute myocardial infarction.Nitric oxide deficiency in chronic kidney disease.Asymmetric dimethylarginine may be a missing link between cardiovascular disease and chronic kidney disease.Elevated asymmetric dimethylarginine alters lung function and induces collagen deposition in mice.Significance of nitric oxide and its modulation mechanisms by endogenous nitric oxide synthase inhibitors and arginase in the micturition disorders and erectile dysfunction.Central sympathetic overactivity: maladies and mechanisms.Asymmetric dimethylarginine inhibits HSP90 activity in pulmonary arterial endothelial cells: role of mitochondrial dysfunctionEvidence of endothelial dysfunction in the development of Alzheimer's disease: Is Alzheimer's a vascular disorder?
P2860
Q21245073-B951FAE5-0F66-490D-96B7-3485A10499DBQ28083755-7517367D-959F-4970-B41C-6D356FB7270AQ28087272-E3F3B8F4-B365-4DAC-8217-5C996CC0978AQ28485286-8E1C2089-9330-4C9B-BAAF-039D3E29AE93Q28581627-AD5C094F-85BE-40B7-9306-DC620A809E48Q30362026-10DBC4D0-22F5-4903-AA32-4A7FDD66C16DQ33799650-D47D659F-2A71-4437-BC64-930A86C716E2Q33805761-1DDDA84E-6308-44FE-835C-D7FCDEF64430Q33889586-5FC61322-B937-4232-8078-AE40C0079A17Q33901576-D8B42204-15F1-423F-BEB3-0FBB9F297E77Q33994067-60E1054C-98BF-4BC1-A7D1-F94484883149Q34442956-370F5890-9402-49E8-909C-F337E3C1107EQ34586093-4471686E-B47B-4ECE-9528-F31626634327Q34721519-355CC718-FB44-44A2-9A3F-1CE176072A1FQ34853745-E8AA2032-7547-4886-8EFB-7C0B434F8C73Q34950263-94EF037E-D23C-4EBD-99B4-B2B8E1188251Q34973956-65F1978E-CF39-4945-B481-5525CC30B5C9Q35048434-13FB99F8-CD6C-4338-B808-64F64D5E462BQ35076387-050835F7-0E47-45D9-B893-8B845FD2B8E6Q35366321-9E29D33A-6525-4E0D-B6DE-26E4611274D5Q35572566-B3A910A5-C3AB-4CE3-A1AD-85547A55F04AQ35584813-20E0E057-4EBE-497D-AEF1-D50C458D2535Q35660101-F496B5E6-E42A-4313-B5C0-9A0A3089E43BQ35669612-1F84E378-0F77-446C-BD3F-DEB0DE8CB8DFQ35952529-2861CD27-C9B7-4109-8F2D-D7DD08D8BE42Q36243862-1F126F8B-0D08-4BD1-BC12-547E26735F29Q36253972-5BCE8CEB-593E-40F7-94B2-C992A4FDD9EEQ36273352-CD3D527D-0C70-4CEC-B28F-0CD7B949198AQ36273357-743B91AD-797A-476C-831C-4451F243C90DQ36381000-F29870B4-38AA-4389-B2F2-1452FCD94A2AQ36409440-4CA26688-7433-4097-99A1-560F7DA0502FQ36438224-4D945A69-4165-4BC6-BF15-02FFE8185374Q36908856-2453B687-19DF-4D2C-BA1A-63A35536F965Q36967585-D47A5BD6-6902-4873-8197-C25771D2A5ABQ36997972-CD2A2266-395A-4495-A28D-3858BE057290Q37078022-AB6597D5-E1C1-4BA6-8FC5-91215CF48276Q37082856-F23094A6-CD31-4199-8872-45E7462FB47BQ37186153-2BE19827-FA04-4B15-A71C-E8D1435C9216Q37274252-62B4B0E3-912B-44CB-AB03-EB9DBB5EA125Q37285389-AD9B2FE8-2EF1-4E78-96FC-7BBF7AB0A09C
P2860
The emerging role of asymmetric dimethylarginine as a novel cardiovascular risk factor.
description
2003 nî lūn-bûn
@nan
2003年の論文
@ja
2003年論文
@yue
2003年論文
@zh-hant
2003年論文
@zh-hk
2003年論文
@zh-mo
2003年論文
@zh-tw
2003年论文
@wuu
2003年论文
@zh
2003年论文
@zh-cn
name
The emerging role of asymmetric dimethylarginine as a novel cardiovascular risk factor.
@ast
The emerging role of asymmetric dimethylarginine as a novel cardiovascular risk factor.
@en
type
label
The emerging role of asymmetric dimethylarginine as a novel cardiovascular risk factor.
@ast
The emerging role of asymmetric dimethylarginine as a novel cardiovascular risk factor.
@en
prefLabel
The emerging role of asymmetric dimethylarginine as a novel cardiovascular risk factor.
@ast
The emerging role of asymmetric dimethylarginine as a novel cardiovascular risk factor.
@en
P1476
The emerging role of asymmetric dimethylarginine as a novel cardiovascular risk factor.
@en
P2093
Rainer H Böger
P304
P356
10.1016/S0008-6363(03)00500-5
P577
2003-10-01T00:00:00Z